The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial
Open accessAbstract
Objective: Systemic lupus erythematosus (SLE) patients exhibit T cell dysfunction, which can be regulated through mitochondrial transmembrane potential (Δψm) and mammalian target of rapamycin (mTOR) by glutathione (GSH). This randomized, double‐blind, placebo‐controlled study was undertaken to examine the safety, tolerance, and efficacy of the GSH precursor N ‐acetylcysteine (NAC). Methods: A total of 36 SLE patients received either daily placebo or 1.2 gm, 2.4 gm, or 4.8 gm of NAC. Disease activity was evaluated monthly by the British Isles Lupus Assessment Group (BILAG) index, the SLE Disease Activity Index (SLEDAI), and the Fatigue Assessment Scale (FAS) before, during, and after a 3‐month treatment period. Mitochondrial transmembrane potential and mTOR were assessed by flow cytometry. Forty‐two healthy subjects matched to patients for age, sex, and ethnicity were studied as controls. Results: NAC up to 2.4 gm/day was tolerated by all patients, while 33% of those receiving 4.8 gm/day had reversible nausea. Placebo or NAC 1.2 gm/day did not influence disease activity. Considered together, 2.4 gm and 4.8 gm NAC reduced the SLEDAI score after 1 month ( P = 0.0007), 2 months ( P = 0.0009), 3 months ( P = 0.0030), and 4 months ( P = 0.0046); the BILAG score after 1 month ( P = 0.029) and 3 months ( P = 0.009); and the FAS score after 2 months ( P = 0.0006) and 3 months ( P = 0.005). NAC increased Δψm ( P = 0.0001) in all T cells, profoundly reduced mTOR activity ( P = 0.0009), enhanced apoptosis ( P = 0.0004), reversed expansion of CD4−CD8− T cells (mean ± SEM 1.35 ± 0.12‐fold change; P = 0.008), stimulated FoxP3 expression in CD4+CD25+ T cells ( P = 0.045), and reduced anti‐DNA production ( P = 0.049). Conclusion: This pilot study suggests that NAC safely improves lupus disease activity by blocking mTOR in T lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dietary supplementation with N-acetylcysteine (a precursor of glutathione) inhibits the mTOR pathway, restores the mitochondrial membrane potential and increases the mitochondrial mass in lymphocytes from patients with SLE85,86”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [85]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, mTOR blockade in patients with SLE treated with N-acetylcysteine or rapamycin reduces both pro-inflammatory T cells and disease activity85,260, suggesting that dietary supplementation or drugs that regulate mitochondrial dynamics might constitute novel therapeutic avenues for mitigating autoantibody production in SLE.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [85]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Derivation of the sledai. A disease activity index for lupus patients
Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570
High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
Demedts, M., Behr, J., Buhl, R., Costabel, U., Dekhuijzen, R., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042976 · Cited by 964
Psychometric qualities of a brief self-rated fatigue measure
Michielsen, H. J., De Vries, J., & Van Heck, G. L. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00392-6 · Cited by 860
Crispín, J. C., Oukka, M., Bayliss, G. P., Cohen, R. A., van Beek, C., Stillman, I. E., Kyttaris, V. C., Juang, Y., & Tsokos, G. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8761 · Cited by 800
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs‐Hoeck, J., Kaupper, T., & Roncarolo, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 746
Glutathione deficiency is associated with impaired survival in HIV disease
Herzenberg, L. A., Rosa, S. C. D., Dubs, J. G., Roederer, M., Anderson, M. T., Ela, S. W., Deresinski, S. C., & Herzenberg, L. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1967 · Cited by 672
Isenberg, D. A., Rahman, A., Allen, E., Farewell, V. T., Akil, M., Bruce, I. N., D’Cruz, D. P., Griffiths, B., Khamashta, M. A., Maddison, P. J., et al. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh624 · Cited by 638
Valencia, X., Yarboro, C. H., Illei, G. G., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2579 · Cited by 590
Quantification of regulatory T cells in patients with systemic lupus erythematosus
Crispín, J. C., Martínez, A. A., & Alcocer-Varela, J. C. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00121-5 · Cited by 406
Flagged first, then by citations
Research works printed but not linked: 1
- Lai Z, 2010, Reversal of CD3+/CD4+/CD25+/Foxp3+ Treg depletion in active SLE patients with rapamycin, Arthritis Rheum, 62, S501
Cited by
Sorted by citations
An emerging role for neutrophil extracellular traps in noninfectious disease
Jorch, S. K., & Kubes, P. (2017) · Nature Medicine · doi:10.1038/nm.4294 · Cited by 1,244
The chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
Normalization of CD4 + T cell metabolism reverses lupus
Yin, Y., Choi, S., Xu, Z., Perry, D. J., Seay, H. R., Croker, B. P., Sobel, E. S., Brusko, T. M., & Morel, L. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0835 · Cited by 614
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Moulton, V. R., Suárez‐Fueyo, A., Meidan, E., Li, H., Mizui, M., & Tsokos, G. C. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.006 · Cited by 491
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 459
The role of neutrophils and NETosis in autoimmune and renal diseases
Gupta, S., & Kaplan, M. J. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.71 · Cited by 442
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 438
Lai, Z.-W., Kelly, R., Winans, T., Marchena, I., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Tily, H., Francis, L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30485-9 · Cited by 412
Self-citationOxidative stress in the pathology and treatment of systemic lupus erythematosus
Perl, A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.147 · Cited by 358
Self-citationOxidative stress in autoimmune rheumatic diseases
Smallwood, M. J., Nissim, A., Knight, A. R., Whiteman, M., Haigh, R. C., & Winyard, P. G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.086 · Cited by 358
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Perl, A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.172 · Cited by 348
Self-citationTargeting metabolism to regulate immune responses in autoimmunity and cancer
Patel, C. H., Leone, R. D., Horton, M. R., & Powell, J. D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0032-5 · Cited by 311
Regulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 301
T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy
Sharabi, A., & Tsokos, G. C. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0356-x · Cited by 298
Yang, Z., Shen, Y., Oishi, H., Matteson, E. L., Tian, L., Goronzy, J. J., & Weyand, C. M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7151 · Cited by 275
Fatigue, Sleep, and Autoimmune and Related Disorders
Zielinski, M. R., Systrom, D. M., & Rose, N. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01827 · Cited by 279
T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity
Moulton, V. R., & Tsokos, G. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78087 · Cited by 250
Ironing out the role of ferroptosis in immunity
Bell, H. N., Stockwell, B. R., & Zou, W. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.019 · Cited by 234
Oxidative stress and its biomarkers in systemic lupus erythematosus
Shah, D., Mahajan, N., Sah, S., Nath, S. K., & Paudyal, B. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-23 · Cited by 230
T cells in Systemic Lupus Erythematosus
Suárez‐Fueyo, A., Bradley, S. J., & Tsokos, G. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.001 · Cited by 230
Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system
Honda, M., & Kubes, P. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.183 · Cited by 230
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
Basta, F., Fasola, F., Triantafyllias, K., & Schwarting, A. (2020) · Rheumatology and Therapy · doi:10.1007/s40744-020-00212-9 · Cited by 227
Perl, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12756 · Cited by 218
Self-citationImmunometabolism in systemic lupus erythematosus
Morel, L. M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.43 · Cited by 219
Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus
Katsuyama, T., Tsokos, G. C., & Moulton, V. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01088 · Cited by 217
Nitric Oxide Signaling in T Cell-Mediated Immunity
García-Ortiz, A., & Serrador, J. M. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.002 · Cited by 201
Metformin and Autoimmunity: A “New Deal” of an Old Drug
Ursini, F., Russo, E., Pellino, G., D’Angelo, S., Chiaravalloti, A., Sarro, G. D., Manfredini, R., & GIORGIO, R. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01236 · Cited by 197
Caza, T. N., Fernandez, D. R., Talaber, G., Oaks, Z., Haas, M., Madaio, M. P., Lai, Z.-W., Miklossy, G., Singh, R. R., Chudakov, D. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203794 · Cited by 193
Self-citationPerl, A., Hanczko, R., Lai, Z.-W., Oaks, Z., Kelly, R., Borsuk, R., Asara, J. M., & Phillips, P. E. (2015) · Metabolomics · doi:10.1007/s11306-015-0772-0 · Cited by 189
Self-citationExtracellular DNA traps in inflammation, injury and healing
Daniel, C., Leppkes, M., Munoz, L. E., Schley, G., Schett, G. A., & i, M. H. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0163-2 · Cited by 194
N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks)
Schwalfenberg, G. (2021) · Journal of Nutrition and Metabolism · doi:10.1155/2021/9949453 · Cited by 188
Kato, H., & Perl, A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40380 · Cited by 185
Self-citationThe Pathology of T Cells in Systemic Lupus Erythematosus
Mak, A., & Kow, N. Y. (2014) · Journal of Immunology Research · doi:10.1155/2014/419029 · Cited by 181
Barnado, A., Crofford, L. J., & Oates, J. C. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5bt0615-234r · Cited by 178
The role of flavonoids in autoimmune diseases: Therapeutic updates
Rengasamy, K. R. R., Khan, H. Z., Gowrishankar, S., Lagoa, R., Mahomoodally, F. M., Khan, Z., Suroowan, S., Tewari, D., Zengin, G., Hassan, S. T. S., et al. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.009 · Cited by 180
Buskiewicz, I. A., Montgomery, T. L., Yasewicz, E. C., Huber, S. A., Murphy, M. P., Hartley, R. C., Kelly, R., Crow, M. K., Perl, A., Budd, R. C., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf1933 · Cited by 181
Self-citationOxidative Stress and Lipid Mediators Modulate Immune Cell Functions in Autoimmune Diseases
Wójcik, P., Gęgotek, A., Žarković, N., & Skrzydlewska, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020723 · Cited by 169
Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease
Joncour, A. L., Martos, R., Loyau, S., Lelay, N., Dossier, A., Cazes, A., Fouret, P. J., Domont, F., Papo, T., Jandrot‐Perrus, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214335 · Cited by 162
TCRαβ + CD3 + CD4 − CD8 − (double negative) T cells in autoimmunity
Brandt, D., & Hedrich, C. M. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.02.001 · Cited by 166
Morris, G., Berk, M., Gałecki, P., Walder, K. R., & Maes, M. H. J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 163
Functional and Phenotypic Plasticity of CD4+T Cell Subsets
Caza, T. N., & LANDAS, S. K. (2015) · BioMed Research International · doi:10.1155/2015/521957 · Cited by 168
Self-citationT-cell metabolism in autoimmune disease
Yang, Z., Matteson, E. L., Goronzy, J. J., & Weyand, C. M. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0542-4 · Cited by 159
Lai, Z., Borsuk, R., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Francis, L., Tily, H., Bartos, Á., Faraone, S. V., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301005 · Cited by 156
Self-citationThe Pathophysiological Role of Neutrophil Extracellular Traps in Inflammatory Diseases
Bonaventura, A., Liberale, L., Carbone, F., Vecchié, A., Díaz-Cañestro, C., Camici, G. G., Montecucco, F., & Dallegri, F. (2018) · Thrombosis and Haemostasis · doi:10.1160/th17-09-0630 · Cited by 157
The comorbidity of ADHD and autism spectrum disorder
Antshel, K. M., Zhang-James, Y., & Faraone, S. V. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.840417 · Cited by 147
Self-citationTherapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
Ibrahim, H., Perl, A., Smith, D. E., Lewis, T. C., Kon, Z. N., Goldenberg, R., Yarta, K., Staniloae, C. S., & Williams, M. R. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108544 · Cited by 151
Self-citationLee, S.-Y., Moon, S., Kim, E., Seo, H.-B., Yang, E., Son, H., Kim, J. K., Min, J., Park, S., & Cho, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1403088 · Cited by 145
DNA Methylation in Systemic Lupus Erythematosus
Hedrich, C. M., Mäbert, K., Rauen, T., & Tsokos, G. C. (2016) · Epigenomics · doi:10.2217/epi-2016-0096 · Cited by 142
N-Acetylcysteine to Combat COVID-19: An Evidence Review
Shi, Z., & Puyo, C. A. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s273700 · Cited by 140
The immunology of systemic lupus erythematosus
Tsokos, G. C. (2024) · Nature Immunology · doi:10.1038/s41590-024-01898-7 · Cited by 142
T Lymphocytes and Autoimmunity
Khan, U., & Ghazanfar, H. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.008 · Cited by 137
Hendriks, C., Drent, M., Elfferich, M., & Vries, J. D. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000496 · Cited by 131
Islam, M. A., Khandker, S. S., Kotyla, P. J., & Hassan, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01477 · Cited by 131
Metabolism as a Target for Modulation in Autoimmune Diseases
Huang, N., & Perl, A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.04.006 · Cited by 130
Self-citationHydrogen peroxide and disease: towards a unified system of pathogenesis and therapeutics
Pravda, J. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00165-3 · Cited by 127
Environmental exposures, epigenetic changes and the risk of lupus
Somers, E. C., & Richardson, B. (2014) · Lupus · doi:10.1177/0961203313499419 · Cited by 115
Review: Metabolic Control of Immune System Activation in Rheumatic Diseases
Perl, A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40223 · Cited by 113
Self-citationDoherty, E. H., Oaks, Z., & Perl, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5702 · Cited by 106
Self-citationGarcia, R. J., Francis, L., Dawood, M., Lai, Z., Faraone, S. V., & Perl, A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37893 · Cited by 105
Self-citationBite of the wolf: innate immune responses propagate autoimmunity in lupus
Gupta, S., & Kaplan, M. J. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144918 · Cited by 106
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
Bjørn, M. E., & Hasselbalch, H. C. (2015) · Mediators of Inflammation · doi:10.1155/2015/648090 · Cited by 100
Li, W., Deng, C., Yang, H., & Wang, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00159 · Cited by 102
Oxidative Stress, T Cell DNA Methylation, and Lupus
Li, Y., Gorelik, G. J., Strickland, F. M., & Richardson, B. C. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38427 · Cited by 94
Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus
Zhang, Q., Yin, X., Wang, H., Wu, X., Li, X., Li, Y., Zhang, X., Fu, C., Li, H., & Qiu, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00976 · Cited by 93
Oaks, Z., Winans, T., Huang, N., Bánki, K., & Perl, A. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0622-8 · Cited by 93
Self-citationFernandez‐Ruiz, R., Paredes, J. L., & Niewold, T. B. (2020) · Translational research · doi:10.1016/j.trsl.2020.12.007 · Cited by 93
Reactive Oxygen Species: Do They Play a Role in Adaptive Immunity?
Bassoy, E. Y., Walch, M., & Martinvalet, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.755856 · Cited by 93
Omarjee, L., Janin, A., Perrot, F., Laviolle, B., Meilhac, O., & Mahé, G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108464 · Cited by 91
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies
Allen, M. E., Rus, V., & Szeto, G. L. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.009 · Cited by 92
Chen, P.-M., Katsuyama, E., Satyam, A., Li, H., Rubio, J., Jung, S., Andrzejewski, S., Becherer, J. D., Tsokos, M., Abdi, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4271 · Cited by 86
Metabolic abnormalities and oxidative stress in lupus
Lightfoot, Y. L., Blanco, L. P., & Kaplan, M. J. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000413 · Cited by 85
Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus
Yang, J. Y., Yang, X., Zou, H., & Li, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2526174 · Cited by 85
Huang, N., Winans, T., Wyman, B., Oaks, Z., Faludi, T., Choudhary, G., Lai, Z., Lewis, J., Beckford, M., Duarte, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46441-2 · Cited by 85
Self-citationLópez-Pedrera, C., Barbarroja, N., Jiménez, Y., Collantes‐Estévez, E., Aguirre, M. A., & Cuadrado, M. J. (2016) · Rheumatology · doi:10.1093/rheumatology/kew054 · Cited by 84
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus
Li, X., Zhang, B., Pan, Y., Shi, G., Ren, J., Fan, H., Dou, H., & Hou, Y. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy088 · Cited by 71
Wang, Y., Tang, J., Yang, Y., Song, H., Fu, J., Gu, Z., & Yu, C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201914264 · Cited by 71
Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome
Radic, M. Z., & Pattanaik, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00969 · Cited by 72
Lee, H.-T., Wu, T.-H., Lin, C.-S., Lee, C.-S., Wei, Y.-H., Tsai, C.-Y., & Chang, D.-M. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.05.007 · Cited by 69
Lee, H.-T., Lin, C.-S., Lee, C.-S., Tsai, C.-Y., & Wei, Y.-H. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12256 · Cited by 69
Álvarez‐Arellano, L., García, N. G., Salazar–García, M., & Corona, J. C. (2020) · Antioxidants · doi:10.3390/antiox9020176 · Cited by 68
Interaction between glutathione and apoptosis in systemic lupus erythematosus
Shah, D., Sah, S., & Nath, S. K. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.12.007 · Cited by 67
Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review
Yuen, H. K., & Cunningham, M. A. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s56063 · Cited by 66
Metabolic regulation of organelle homeostasis in lupus T cells
Caza, T. N., Talabér, G., & Perl, A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.07.001 · Cited by 65
Self-citationN-acetylcysteine in dermatology
Adil, M., Amin, S. S., & Mohtashim, M. (2018) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/ijdvl.ijdvl_33_18 · Cited by 65
Neutrophil-Extracellular Traps, Cell-Free DNA, and Immunothrombosis in Companion Animals: A Review
Goggs, R. A. N., Jeffery, U., LeVine, D. N., & Li, R. H. L. (2019) · Veterinary Pathology · doi:10.1177/0300985819861721 · Cited by 65
Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway
He, J., Ma, J., Ren, B., & Liu, A. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.09.022 · Cited by 69
Kawka, L., Schlencker, A., Mertz, P., Martin, T., & Arnaud, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173996 · Cited by 63
Empowering Regulatory T Cells in Autoimmunity
Kasper, I. R., Apostolidis, S. A., Sharabi, A., & Tsokos, G. C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.003 · Cited by 65
Glycolysis in Innate Immune Cells Contributes to Autoimmunity
Xu, Y., Chen, Y., Zhang, X., Ma, J., Liu, Y., Cui, L., & Wang, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.920029 · Cited by 63
Yan, Z., Chen, Q., & Xia, Y. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s399284 · Cited by 62
Jing, Y., Luo, L., Chen, Y., Westerberg, L. S., Zhou, P., Xu, Z. P., Herrada, A. A., Park, C.-S., Kubo, M., Mei, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00749-3 · Cited by 61
Interplay of Infections, Autoimmunity, and Immunosuppression in Systemic Lupus Erythematosus
Caza, T. N., Oaks, Z., & Perl, A. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2013.863305 · Cited by 60
Self-citationWong, K. K., Lee, S. W. H., & Kua, K. P. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s306849 · Cited by 62
Low‐density granulocytes in systemic autoimmunity and autoinflammation
Carmona‐Rivera, C., & Kaplan, M. J. (2022) · Immunological Reviews · doi:10.1111/imr.13161 · Cited by 60
Pathogenesis and treatment of autoimmune rheumatic diseases
Liu, E. V., & Perl, A. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000594 · Cited by 59
Self-citationImmunometabolic Pathways and Its Therapeutic Implication in Autoimmune Diseases
Wang, T., Jiao, Y., & Zhang, X. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08821-6 · Cited by 61
Lu, Y., Dong, Y., Zhang, Y., Shen, D., Wang, X., Ge, R., Zhang, M., Xia, Y., & Wang, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15321 · Cited by 58
Choi, M. Y., & Costenbader, K. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.890522 · Cited by 58
Environmental agents, oxidative stress and autoimmunity
Khan, M. F., & Wang, G. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.10.012 · Cited by 58
Metadata
- Authors
- Lai, Z., Hanczko, R., Bonilla, E., Caza, T. N., Clair, B., Bartos, A., Miklossy, G., Jimah, J., Doherty, E., Tily, H., Francis, L., Garcia, R., Dawood, M., Yu, J., Ramos, I., Coman, I., Faraone, S. V., Phillips, P. E., & Perl, A.
- Affiliations
- SUNY Upstate Medical University (US)
- ORCID
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-08-27
- Volume
- 64
- Issue
- 9
- Pages
- 2937-2946
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC3411859
- OpenAlex
- W2015010210
- Cited by
- 428
- References
- 32
- Citations by year
- 2026: 29 · 2025: 31 · 2024: 39 · 2023: 35 · 2022: 36 · 2021: 40 · 2020: 42 · 2019: 36 · 2018: 45 · 2017: 16 · 2016: 25 · 2015: 23 · 2014: 11 · 2013: 17 · 2012: 3
- FWCI
- 13.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI072648, R01AI072648)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR076092)
- National Center for Complementary and Integrative Health (AT-004332, R01AT004332)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- systemic lupus erythematosus, N-acetylcysteine, glutathione precursor, mTOR inhibition, T cell dysfunction, mitochondrial membrane potential, disease activity, fatigue, apoptosis, CD4+CD8+ T cells, drug safety and tolerability, immunomodulatory therapy, SLEDAI, BILAG index, Fatigue Assessment Scale
- MeSH terms
- Acetylcysteine, Adult, Double-Blind Method, Female, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Pilot Projects, Placebos, Severity of Illness Index, T-Lymphocytes, Free Radical Scavengers, Treatment Outcome, Membrane Potential, Mitochondrial, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
